Skip to content

    Recently Viewed


      A collage of research scientists and medical imaging

      What you need to know about Johnson & Johnson’s 2023 fourth-quarter and full-year earnings report

      Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Innovative Medicine and MedTech businesses.

      Share Article
      share to

      This morning, Johnson & Johnson shared its 2023 fourth-quarter and full-year earnings report.

      Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 130,000 employees across the globe working every day to help change the trajectory of health for humanity.

      “Johnson & Johnson delivered strong results in 2023 while we continued to invest in advancing and strengthening our pipeline,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “Our diverse portfolio offers innovative solutions from both our Innovative Medicine and MedTech businesses and, coupled with a multifaceted approach to capital allocation, provides the foundation for us to further improve health outcomes for patients and deliver significant value to shareholders.”

      For more details about the company’s 2023 fourth-quarter and full-year results, and to read a message from Chairman and Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.

      2023 earnings infographic

      Johnson & Johnson’s 2023 Earnings

      Read the earnings press release, which includes fourth-quarter and full-year financial data for 2023.

      Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

      More from Johnson & Johnson

      Close-up of a woman with low vision receiving an eye exam exam with a doctor shining light into her left eye

      What is low vision?

      Low vision isn’t the same as blindness, but navigating daily life with it is still challenging. For Low Vision Awareness Month, learn the facts—plus, the promising treatment innovations that are in the works.
      A female scientist conducting research in a laboratory, focusing on orphan drugs for rare diseases

      What is an orphan drug?

      The need for these rare disease therapies is strong, and access to them can be lifesaving. Here’s how Johnson & Johnson is innovating to help give patients options.
      Caring & giving
      Sam Seavey piloting an aircraft from the cockpit

      3 health advocates; 1 Johnson & Johnson program that offers empowerment and connection

      In the quest to solve the toughest health challenges, innovating therapies and finding treatments are essential—but so is supporting the patients living with these diseases. That’s exactly why Johnson & Johnson launched HealtheVoices a decade ago.
      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.